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Equal mitotic chromosome segregation is critical for
genome integrity and is monitored by the spindle as-
sembly checkpoint (SAC).We have previously shown
that the consensus phosphorylation motif of the
essential SAC kinase Monopolar spindle 1 (Mps1) is
very similar to that of Polo-like kinase 1 (Plk1). This
prompted us to ask whether human Plk1 cooperates
with Mps1 in SAC signaling. Here, we demonstrate
that Plk1 promotes checkpoint signaling at kine-
tochores through the phosphorylation of at least
two Mps1 substrates, including KNL-1 and Mps1 it-
self. As a result, Plk1 activity enhances Mps1 cata-
lytic activity as well as the recruitment of the SAC
components Mad1:C-Mad2 and Bub3:BubR1 to ki-
netochores. We conclude that Plk1 strengthens the
robustness of SAC establishment at the onset of
mitosis and supports SAC maintenance during pro-
longed mitotic arrest.INTRODUCTION
The spindle assembly checkpoint (SAC) ensures equal chromo-
some segregation during eukaryotic cell division (Lara-Gonza-
lez et al., 2012; Musacchio and Salmon, 2007; Vleugel et al.,
2012). Consequently, its deregulation results in aneuploidy,
loss of genome integrity, and increased tumorigenic potential.
The SAC delays progression through mitosis until all sister
chromatids are attached via their kinetochores (KTs) to micro-
tubules (MTs) emerging from opposite spindle poles. Central
to the SAC is a diffusible effector, known as the mitotic check-
point complex (MCC), that inhibits the anaphase-promoting
complex/cyclosome (APC/C), a ubiquitin ligase required for
the degradation of early mitotic proteins. In turn, APC/C con-
trols the onset of sister chromatid separation and mitotic exit
through proteolytic degradation of the Separase inhibitor Se-
curin and the Cdk1 activator Cyclin B, respectively. The estab-66 Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authorslishment and maintenance of the MCC-based inhibitory signal
requires the protein kinase Monopolar spindle 1 (Mps1) (Liu
and Winey, 2012), which accumulates and autoactivates at
unattached or misaligned KTs. Active Mps1 is important for
the recruitment of numerous checkpoint components, including
Mad1:C-Mad2 and Bub3:BubR1 complexes (Funabiki and
Wynne, 2013), that then cooperate to form MCC: upon binding
to KTs, Mad1:C-Mad2 catalyzes the conformational activation
of additional Mad2 molecules, resulting in the closed conformer
C-Mad2. C-Mad2 associates in an inhibitory sub-complex with
the APC/C coactivator Cdc20. In a parallel process, Mps1
phosphorylates an array of Met-Glu-Leu-Thr (MELT) motifs
within the KT-associated protein KNL-1, which then acts
as a recruitment platform for Bub3:Bub1 and Bub3:BubR1
complexes (Krenn et al., 2014; London et al., 2012; Overlack
et al., 2015; Primorac et al., 2013; Shepperd et al., 2012;
Vleugel et al., 2013, 2015; Yamagishi et al., 2012). Accumu-
lating Bub3:BubR1 and C-Mad2:Cdc20 sub-complexes finally
combine to form the APC/C-inhibitory MCC (Lara-Gonzalez
et al., 2012).
The aforementioned functions place Mps1 at the core of SAC
signaling, but surprisingly few physiological substrates have, so
far, been described for this kinase. In human cells, these include
Mps1 itself, the KNL-1/Mis12/Ndc80 complex (KMN) network
component KNL-1, and Borealin (Funabiki and Wynne, 2013;
Liu and Winey, 2012). Mass spectrometric analysis of in vivo au-
tophosphorylation sites (Dou et al., 2011), as well in vitro phos-
phorylated peptide libraries (Hennrich et al., 2013), revealed a
strong preference of Mps1 for acidic residues in the 2 position
relative to the phosphoacceptor site. Remarkably, this motif
preference is very similar to that described for Polo-like kinase
1 (Plk1) (Nakajima et al., 2003; Santamaria et al., 2011), a key
regulator of mitotic progression (Petronczki et al., 2008).
This raised the question of whether the two kinases might coop-
erate in SAC signaling through phosphorylation of common sub-
strates. Similar to Mps1, Plk1 accumulates at unaligned KTs, but
its role in SAC signaling remains controversial (Petronczki et al.,
2008): in many instances, inhibition or depletion of Plk1 causes a
SAC-dependent arrest, arguing that Plk1 is not strictly required
for SAC signaling, but, in some species, Plk1 contributes to
SAC signaling through positive effects on the KT recruitment of
SAC components.
The present study aims at clarifying the role of Plk1 in SAC
signaling in human cells. We show that Plk1, indeed, strengthens
SAC signaling but that this role is generally masked by additional
functions of Plk1—notably, its contribution to bipolar spindle for-
mation. Our data support amodel according to which Plk1 coop-
erates with Mps1 through a shared preference for similar phos-
phorylation consensus motifs within substrates. Specifically,
we identify Mps1 autophosphorylation sites, as well as MELT
motifs within KNL-1, as common substrates for both kinases.
Collectively, not only do our results demonstrate a synergistic
role of Plk1 and Mps1 in the regulation of SAC signaling, but
they also provide a molecular basis for the observed synergy.
RESULTS
Human Plk1 and Mps1 Cooperatively Regulate
Checkpoint Establishment and Maintenance
The similarity between the preferred phosphorylation sites of
Mps1 and Plk1 raised the possibility of functional cooperation.
We reasoned that a role for Plk1 in SAC signaling might previ-
ously have escaped detection because of the essential roles of
Plk1 in bipolar spindle formation and KT-fiber stabilization.
Therefore, we carried out initial experiments in cells that had
been treated with high doses of the MT-depolymerizing drug no-
codazole, thereby maximizing the strength of the SAC signal.
Moreover, we reasoned that a potential synergy between Plk1
andMps1 in SAC signaling might be more readily detectable un-
der conditions of partially impaired Mps1 activity. Asynchro-
nously growing human RPE-1 cells were, therefore, treated
with nocodazole and analyzed by time-lapse imaging in the pres-
ence or absence of kinase inhibitors (Figure 1A). In the absence
of nocodazole, inhibition of Plk1 by TAL (Santamaria et al., 2007)
caused spindle collapse and mitotic arrest, while inhibition of
Mps1 by Reversine (Santaguida et al., 2010) caused a SAC
override, regardless of the activity state of Plk1, as expected
(Figure 1A). At a low dose of nocodazole (0.1 mg/ml), the effect
of single Plk1 inhibition on SAC signaling was difficult to discern,
presumably reflecting residual MTs interacting with KTs (Yang
et al., 2009), but synergy with Mps1 inhibition could be observed
(Figure 1A). When nocodazole was used at a dose (1 mg/ml)
causing complete depolymerization of MTs (Yang et al., 2009),
inhibition of Plk1 reduced the duration of checkpoint arrest
from 31 hr to 21 hr, inhibition of Mps1 reduced this time to
11 hr, and simultaneous inhibition of both kinases clearly
produced a strong synergistic effect, causing almost immediate
slippage (Figures 1A, S1A, and S1B). Synergy between Plk1 and
Mps1 could also be demonstrated using small interfering RNA
(siRNA) to deplete Plk1 (Figure S1C) or using ATP analogs for
kinase inhibition in cell lines harboring corresponding analog-
sensitive versions of the two kinases (Burkard et al., 2007; Ma-
ciejowski et al., 2010) (Figures S1D and S1E). Furthermore,
similar results were obtained for a range of transformed and un-
transformed cell lines, representing different tissues (cervix, co-
lon, and retina) and different degrees of karyotypic complexity
(Figure S1F). We conclude that, under conditions of maximal
SAC signal strength, simultaneous interference with Plk1 andMps1 causes more drastic weakening of the SAC than inhibition
of Mps1 alone.
Next, we examined the consequences of Plk1 inhibition on key
SAC components. No significant effects could be seen at the
level of protein expression (Figure S1G). In contrast, Plk1 inhibi-
tion had a major impact on the KT recruitment of Mad1, as visu-
alized in RPE-1 cells that had been arrested in the M phase by
treatment with the proteasome inhibitor MG132 (Figure 1B).
While Mad1 was absent from KTs in control cells, indicating
completion of bipolar spindle formation and silencing of the
SAC, inhibition of Plk1 triggered collapse of the spindle and
concomitant re-recruitment of Mad1 to KTs. As expected, this
restoration of KT Mad1 was dependent on Mps1 activity (Fig-
ure 1B). Strikingly, however, when analogous experiments
were carried out in the complete absence of MTs, maximal KT
recruitment of Mad1 was only seen when both Plk1 and Mps1
were active (Figure 1B). Similarly, inhibition of Plk1 led to an ad-
ditive effect on Mad1 KT recruitment when analog-sensitive
Mps1 was inhibited with the ATP analog 3-MB-PP1 (Figure S1H).
These results demonstrate that Plk1 activity is required for
maximal recruitment of the SAC component Mad1 to KTs. To
extend the aforementioned findings to Mad2, the major binding
partner of Mad1, we used an RPE-1 cell line harboring an
EGFP-tagged version of Mad2 that had been genetically engi-
neered through introduction of the EGFP coding sequence
into the 50 end of one of the two endogenous MAD2L1 loci
(Figure S1I). In these cells, KT recruitment of Mad2 was as
dependent on both Plk1 and Mps1 as that of Mad1 (Figure S1J).
Virtually identical observations were made when using an anti-
body specific for the closed conformation of Mad2 (C-Mad2)
(data not shown). Taken together, the aforementioned results
demonstrate that Plk1 andMps1 cooperate in the KT recruitment
of the Mad1:C-Mad2 complex.
Having shown that Plk1 cooperates with Mps1 in the estab-
lishment of the SAC, we asked whether this kinase also contrib-
utes to SACmaintenance. RPE-1 cells expressing endogenously
taggedMad2were arrested in theMphasewith nocodazole, and
their ability to maintain a prolonged SAC arrest was determined
by time-lapse imaging (Figure 1C; Movie S1; since TAL displays
auto-fluorescence, the chemically distinct Plk1 inhibitor BI-2536
[Petronczki et al., 2008] was used for these experiments). While
treatment with either Plk1 orMps1 inhibitor resulted in a progres-
sive loss of EGFP-Mad2 from KTs (Figure 1C) and a concomitant
shortening of mitotic arrest (Figure 1C, right panel), the simulta-
neous inhibition of both kinases produced additive effects. This
demonstrates that cooperation between Plk1 andMps1 also oc-
curs during maintenance of the SAC.
Next, we considered it important to extend our conclusions to
cells undergoing unperturbed mitosis. To avoid possible compli-
cations from the role of Plk1 in KT-fiber stability, we focused
attention on cells at the early stages of mitosis (prophase and
prometaphase), which are characterized by unstable lateral in-
teractions between MTs and KTs, or a complete lack thereof,
rather than end-on attachments (Magidson et al., 2011). Specif-
ically, we quantified the KT recruitment of C-Mad2 at the onset of
nuclear envelope breakdown (late prophase, visualized by stain-
ing of the nuclear pore complex protein TPR), at the time of
chromosome ring formation (early prometaphase), and at theCell Reports 12, 66–78, July 7, 2015 ª2015 The Authors 67
Figure 1. Human Plk1 and Mps1 Cooperatively Regulate Checkpoint Establishment and Maintenance
(A) Asynchronously growing RPE-1 cells were treated with the anti-MT drug nocodazole and solvent only (control), the Mps1 inhibitor Reversine, the Plk1 inhibitor
TAL, or both inhibitors combined and analyzed by time-lapse imaging. Scatterplots show time in mitosis; 10–30 cells per conditions. aver, average; h, hours.
(B) RPE-1 cells pretreated with MG132 were incubated for 1 hr in the presence or absence of nocodazole and indicated inhibitors. Cells were analyzed by
immunofluorescence (IF) microscopy, and human CREST antiserum was used to identify KTs. Left: chromosome alignment states at the end of incubation;
percentages indicate the frequencies of shown spindle morphologies. Right: scatterplot depicts Mad1 staining intensity at KTs; 28–39 cells per condition. Rev,
Reversine; rel. signal int., relative signal intensity.
(C) RPE-1 cells expressing endogenously EGFP-tagged Mad2 (Figure S1I) were synchronized in mitosis by incubation with nocodazole, followed by the addition
of the indicated kinase inhibitors and time-lapse imaging. Left: stills from live recordings (Movie S1). Middle: traces illustrating loss of EGFP-Mad2 from KTs; n = 8
cells per condition, shaded areas represent SEM. Right: quantification of the time in mitosis; n = 41–49 cells per condition. int., intensity. Scale bars, 5 mm.
***p < 0.001 (from Student’s t tests). See also Figure S1I and Movie S1.beginning of chromosome biorientation (late prometaphase). In
both late prophase and early prometaphase cells, inhibition of
Plk1 strongly reduced the KT recruitment of both C-Mad2 (Fig-
ure 2; Figure S2A) and Mad1 (Figure S2B), demonstrating that
Plk1 promotes SAC establishment during the early stages of
an otherwise unperturbed mitosis.
Plk1 Inhibition Acts on the KT Branch of the SAC
Elegant recent studies have demonstrated that MCC generated
during late interphase and early mitosis originates at two distinct
sources (Rodriguez-Bravo et al., 2014). The first pool of MCC is
assembled at nuclear envelopes already prior to the onset of
mitosis, thereby ensuring a minimal level of anaphase-onset68 Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authorsinhibitory SAC signal until the second pool of MCC can be gener-
ated from unattached KTs. Mps1 is implicated in the generation
of both pools ofMCC (Maciejowski et al., 2010), raising the ques-
tion of whether Plk1 cooperates with Mps1 already during inter-
phase. Inhibition of Mps1 was previously shown to substantially
reduce the levels of Cyclin B1 that are detectable within the nu-
cleus at the onset of mitosis, providing a convenient readout for
the generation of interphase MCC (Maciejowski et al., 2010).
Moreover, examination of the rate of Cyclin B1 destruction in
cells undergoing mitosis in the presence of a high dose of noco-
dazole provided a readout for the activity of the KT-borne branch
ofMCC. For bothmeasurements, we used RPE-1 cells harboring
a Venus-tagged version of theCCNB1 gene (Collin et al., 2013) to
Figure 2. Plk1 Inhibition Delays SAC Activation in Unperturbed Mitosis
Left: asynchronously growing RPE-1 cells were incubated with kinase inhibitors or solvent for 2 hr and analyzed by IF, using the indicated antibodies. Mitotic
phases were determined as described in Results (see also Figure S2A).
Right: KT recruitment of C-Mad2 was measured at different stages of mitosis; scatterplot shows results for n = 377–456 KT pairs from 10–13 cells per condition.
fluor. int., fluorescence intensity. Scale bar, 5 mm. ***p < 0.001 (from Student’s t tests).
See also Figure S2A.monitor Cyclin B1 levels by fluorescence time-lapse imaging
(Figures 3A and 3B; Movie S2). In agreement with previous ob-
servations (Maciejowski et al., 2010), cells treated with the
Mps1 inhibitor Reversine showed a marked reduction of Venus
fluorescence in the nuclei of prophase cells, suggesting reduced
activity of interphase MCC (Figures 3A and 3B; t = 0). Remark-
ably, however, addition of the Plk1 inhibitor BI-2536 did not de-
tectably lower the nuclear levels of Cyclin B1 (Figures 3A and 3B;
t = 0), suggesting that Plk1 does not contribute to the generation
of interphase MCC. One caveat to this conclusion is that high
levels of Cyclin B could also reflect, at least in part, a role of
Plk1 in the activation of APC/C (Petronczki et al., 2008). The ac-
tivity of the KT-borne branch of MCC could be assessed in the
same experiment by monitoring the kinetics of Cyclin B1 degra-
dation (Figure 3B; t = 20–200). While inhibition of either Plk1 or
Mps1 caused a marked acceleration of mitotic exit, the simulta-
neous inhibition of both kinases resulted in a precipitous drop of
Cyclin B1 levels. These results led us to conclude that Plk1 con-
tributes primarily to the KT-borne branch of SAC signaling. This
conclusion is further supported by experiments showing that
Mps1 inhibition causes only partial removal of Plk1 from KTs
(Figure S3A) and no detectable effect on global Plk1 activity (Fig-
ure S3B). Moreover, Plk1 needs to be associated with KTs for
SAC signaling (Figures S3C and S3D).
The Effect of Plk1 Inhibition on SAC Signaling Does Not
Involve Delocalization or Reduced Catalytic Activity of
Aurora B
We considered the possibility that the effect of Plk1 on SAC
signaling might be mediated by Aurora B kinase, which pro-
motes Mps1 KT recruitment and reduces KT-associated phos-
phatase 1 activity (Hewitt et al., 2010; Maciejowski et al., 2010;
Maldonado and Kapoor, 2011; Rodriguez-Bravo et al., 2014;
Santaguida et al., 2010, 2011; Vigneron et al., 2004). AuroraB is recruited to centromeres in response to phosphorylation
of histone H2A (on Thr120) and histone H3 (on Thr3) by the
kinases Bub1 and Haspin, respectively (van der Horst and
Lens, 2014). Although inhibition of Plk1 in mitotically arrested
RPE-1 cells showed a marginal reduction of Thr3 phosphoryla-
tion (by about 20%), consistent with a reported role for Plk1 in
Haspin activation (Zhou et al., 2014), this was not sufficient to
detectably reduce Aurora B levels at centromeres (Figure 4A;
Figure S4A). In contrast, Aurora B centromere levels dropped
by 40% when histone H3 Thr3 phosphorylation was almost
completely abolished in response to Haspin inhibition by 5-io-
dotubercidin (5-ITu), as expected (De Antoni et al., 2012).
The lack of significant effects of Plk1 inhibition on Aurora
B localization was also confirmed in RPE-1 cells expressing
endogenously EGFP-tagged Aurora B, generated by the intro-
duction of an EGFP tag into one allele of the AURKB gene (Fig-
ure S4B). Live-cell imaging revealed that single or combined
inhibition of Plk1 and/or Mps1 did not detectably impair Aurora
B recruitment, while inhibition of Haspin produced the ex-
pected inhibitory effect (Figure 4B). Conversely, the concomi-
tant inhibition of Plk1 and Mps1 strongly reduced Mad1 levels
at KTs, whereas the inhibition of Haspin had no effect (Figures
4C and S4C). These results demonstrate that Plk1 regulates
SAC signaling, as monitored by Mad1 recruitment, through
mechanisms that are independent of any potential effects on
Aurora B localization.
To extend the aforementioned conclusion to the catalytic
activity of Aurora B, we took advantage of the Aurora B biosen-
sors tethered to either chromatin (histone H2B) or centromeres
(centromere protein B [CENP-B]) (Fuller et al., 2008). Inhibition
of Plk1 or Mps1, either individually or in combination, did
not detectably alter fluorescence resonance energy transfer
(FRET) efficiency (Figure 4D; Movie S3). In contrast, direct inhi-
bition of Aurora B by ZM-447439 completely abolished sensorCell Reports 12, 66–78, July 7, 2015 ª2015 The Authors 69
Figure 3. Plk1 Inhibition Acts on the KT Branch of the SAC
Asynchronous RPE-1 cells expressing endogenously Venus-tagged Cyclin B1
were incubated with nocodazole and indicated inhibitors, followed by time-
lapse imaging.
(A) Scatterplots depict levels of Cyclin B1-Venus at the indicated cell cycle
stages; time is indicated relative to nuclear translocation of Cyclin B1-Venus
(n = 20–29 cells per condition). Prometaph., prometaphase.
(B) Upper: micrographs represent still images from live recordings (Movie S2);
time stamps indicate time relative to nuclear translocation of Cyclin B1-Venus.
Scale bar, 5 mm. Lower: tracings illustrating levels of Cyclin B1 before nuclear
envelope breakdown (time = 0) as well as kinetics of subsequent degradation
(n = 7–12 cells per condition). Shaded areas represent SEM. Rev, Reversine;
int., intensity.
See also Movie S2.
70 Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authorsphosphorylation, as expected (Figure 4D). While combined
inhibition of Plk1 and Mps1 resulted in a more rapid SAC over-
ride than inhibition of Mps1 alone (Figure 4D), Aurora B inhibi-
tion did not cause mitotic slippage within the observation
period, supporting our conclusion that loss of Aurora B activity
cannot explain the observed effect of combined Plk1 and
Mps1 inhibition. Fully consistent results were obtained in exper-
iments using a centromere-targeted FRET sensor (Figure S4D);
phospho-specific antibodies against histone H3 (Ser10) and
CENP-A (Thr7), two well-characterized Aurora B substrates
(De Antoni et al., 2012) (Figures 4E and S4E); and a Mis12-
Mps1 construct conferring constitutive KT localization (Fig-
ure S4F). Collectively, these results strongly argue that Plk1
inhibition does not affect Aurora B localization or activity to
an extent that could explain the cooperation between Plk1
and Mps1 in SAC signaling.
Plk1 and Mps1 Both Target KNL-1 MELT Motifs
MCC production from KTs results from the convergence of
two major pathways. One involves the KT recruitment of a
Mad1:C-Mad2 complex, which then allows the formation of C-
Mad2:Cdc20; the other is centered on the KMN complex
component KNL-1, which has emerged as an important hub
for the assembly of Bub3:Bub1 and Bub3:BubR1 complexes
(see Introduction). Our data clearly indicate that Plk1 cooperates
with Mps1 in the KT recruitment of the Mad1:C-Mad2 complex,
but this does not exclude additional levels of cooperation. To
explore this possibility, we asked whether Plk1 inhibition would
still cooperate with Mps1 inhibition when Mad1 was constitu-
tively targeted to KTs through fusion to Mis12. As shown in Fig-
ure S5A, combined inhibition of Plk1 and Mps1 produced a
synergistic effect on the timing of mitotic exit even in these cells,
arguing that Plk1 does more than simply cooperate with Mps1 in
the KT recruitment of Mad1.
The aforementioned result led us to focus on the second arm
of KT-dependent SAC signaling, the one centered on KNL-1.
Mps1 is known to phosphorylate KNL-1 on a series of MELT
motifs, which then triggers the recruitment of Bub3:Bub1 and
Bub3:BubR1 complexes, prompting us to ask whether these
phosphorylation sites might also be targeted by Plk1. Synthetic
peptides representing all 19 MELTmotifs of human KNL-1 (Vleu-
gel et al., 2013) were spotted onto membranes and exposed to
recombinant Plk1 in the presence of g-32P-ATP. Remarkably,
Plk1 readily and specifically phosphorylated 13 of these sites
(Figure 5A; Figure S5B), including motifs that have recently
been shown to be targeted by Mps1 (Thr875, NDMDITKSY) (Ya-
magishi et al., 2012) and to be sufficient for KNL-1 function
(DDMEITRSHTTA) (Vleugel et al., 2013). To extend these
in vitro results to living cells, we used the KNL-1 Thr875 site to
generate a chromatin (H2B)-targeted FRET reporter (Figure S5C;
Movie S4). After expression of this FRET reporter in HeLa cells,
we could readily demonstrate reduced phosphorylation in
response to Plk1 inhibition (Figure 5B), arguing that Plk1 is,
indeed, capable of phosphorylating KNL-1 MELT motifs in vivo.
Sensitivity to Mps1 inhibition could not be demonstrated in this
experiment, presumably reflecting low abundance of cytosolic
Mps1 (Saurin et al., 2011). However, we emphasize that this
same reporter was similarly sensitive to Plk1 or Mps1 inhibition
Figure 4. The Effect of Plk1 Inhibition on SAC Signaling Does Not Involve Delocalization or Reduced Catalytic Activity of Aurora B
In (A)–(C) and (E), RPE-1 cells were preincubated for 2 hr with MG132 and then treated with nocodazole and the indicated kinase inhibitors for 1 hr.
(A) Histogram shows the phosphorylation state of histone H3 Thr3 and centromere levels of Aurora B as determined by IF (n = 25–35 cells per condition); mi-
crographs are shown in Figure S4A. rel. signal int., relative signal intensity.
(B) Left: EGFP centromere signals captured from living cells expressing endogenously EGFP-tagged Aurora B (Figure S4B). Right: scatterplot showing EGFP
signals for n = 120 centromeres from 15 cells per condition. Rev., Reversine.
(C) Histogram shows Mad1 KT levels as determined by IF analysis (n = 31–39 cells per condition; micrographs are shown in Figure S4C).
(D) Asynchronously growing HeLa cells stably expressing a chromatin-targeted FRET sensor for Aurora B activity were incubated with nocodazole and kinase
inhibitors and monitored by time-lapse ratio imaging (Movie S3). Left: heatmap representation of reporter phosphorylation; time is indicated relative to mitotic
entry. Right: traces illustrating the results from n = 14–22 cells per condition; shaded areas represent SEM.
(E) Histogram shows the quantification of IF signals produced by phospho-specific antibodies detecting Aurora B targets. Signals were quantified over chro-
mosome arms for phospho-Ser10 on histone H3 and over centromeres for phospho-Thr7 on CENP-A (n = 24–29 cells per condition; micrographs are shown in
Figure S4E).
Scale bars, 5 mm. Error bars indicate SEM. ***p < 0.001 (from Student’s t tests); ns, not significant. See also Figure S4 and Movie S3.when tethered to KTs, confirming cooperativity between the two
kinases (data not shown). Cooperativity in the phosphorylation of
Thr875 could also be demonstrated using a phospho-specific
antibody (Yamagishi et al., 2012) to stain RPE-1 cells: while
inhibition of either Plk1 or Mps1 significantly reduced signal
intensity at KTs, combined kinase inhibition clearly produced ad-
ditive effects (Figures 5C and S5D). The most straightforward
interpretation of these results is that Plk1 and Mps1 cooperate
to target endogenous KNL-1 on MELT motifs. To rule out the
alternative explanation that Plk1 might enhance KNL-1 phos-phorylation through indirect effects on phosphatases antago-
nistic to Mps1, we treated RPE-1 cells with high doses of oka-
daic acid (500 nM), which are known to inhibit both PP1 and
PP2A (De Antoni et al., 2012). While okadaic acid enhanced
Thr875 phosphorylation, as expected, it did not abolish the effect
of Plk1 inhibition (Figure S5E), arguing that Plk1 phosphorylates
this site directly. Likewise, okadaic acid did not affect the impact
of Plk1 inhibition on the KT recruitment of Mad1 (Figure S5E).
To demonstrate that the phosphorylation of KNL-1 MELT mo-
tifs by Plk1 resulted in important physiological consequences,Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authors 71
Figure 5. Plk1 and Mps1 Both Target KNL-1 MELT Motifs
(A) Autoradiography shows the results of in vitro peptide spotting kinase assays. Peptides containing the MELT motif (shaded areas) were synthesized carrying
the Thr phosphoacceptor (T, arrowhead) or an Ala (A) in the corresponding position and incubated with g-32P-ATP in the presence (+Plk1) or absence (no enzyme)
of recombinant Plk1. Additional peptides carrying Ala in place of potentially interfering phosphoacceptors were also analyzed. Equal synthesis of peptides was
monitored by hydration of membranes prior to side-chain de-protection (peptide).
(B) The motif around KNL-1 Thr875 was used to design a MELT-based FRET sensor (Figure S5C) targeted to chromatin by H2B fusion. To determine the
specificity of MELT phosphorylation, Thr875 was substituted with Ala. HeLa S3 cells expressing the FRET reporters were enriched inmitosis with nocodazole and
additionally treated with MG132 and 100 nM BI-2536 before CFP/FRET ratios were determined by live-cell microscopy. Left: heatmap representation of reporter
phosphorylation. Right: scatterplot shows emission ratios from n = 17–31 cells per condition.
(C) RPE-1 cells were synchronized in metaphase using MG132 and subsequently treated with nocodazole and kinase inhibitors. Left: KNL-1 phosphorylation site
occupancy, as determined by IF staining with an antibody specific for phospho-Thr875. Right: histogram shows quantification of P-Thr875 IF staining (n = 50–62
cells per condition). Rev., Reversine; rel. signal int., relative signal intensity. Error bars indicate SEM.
(D and E) Plk1 inhibition reduces Bub3:BubR1 complex recruitment to KTs. RPE-1 cells (D) or RPE-1 cells expressing endogenously EGFP-tagged Bub3 (E;
Figure S5H) were treated as described in (C) and analyzed by IF, using the indicated antibodies; scatterplots show results from quantitative IF (n = 65–69 cells per
condition; micrographs are shown in Figure S5I).
Scale bars, 5 mm. ***p < 0.001 (from Student’s t tests). See also Figure S5.we sought to correlate the effect of Plk1 inhibition on KNL-1
phosphorylation with the KT recruitment of the Bub3:BubR1
complex. Indeed, inhibition of Plk1 lowered not only Thr875
phosphorylation but also BubR1 (Figures 5D, S5F, and S5G) as72 Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authorswell as EGFP-Bub3 signals at KTs (Figures 5E, S5H, and S5I).
Notably, quantification revealed a strong correlation between
the reductions in MELT motif phosphorylation and KT recruit-
ment of these SAC signaling components (Figures 5E and S5I).
Figure 6. Plk1 Targets Mps1 Autophosphorylation Sites In Vitro
(A)Mixtures of recombinant Plk1 andMps1were incubated for 2minwith g-32P-ATP andwith kinase inhibitors as indicated. Phosphorylation of the Plk1 substrate
casein was monitored for control. Phosphorylation of Mps1 and casein was detected by autoradiography (32P), levels of Plk1 and Mps1 were monitored by
western blotting (WB), and casein was visualized by Ponceau S (PS) staining. Rev., Reversine.
(B) Autoradiography and WB illustrate the time course of in vitro Mps1 phosphorylation in the presence or absence of Plk1 and Reversine (left). Quantitative data
(right) were averaged from two distinct experiments.
(C) Autoradiography shows the results of peptide spotting kinase assays performed as described in the legend for Figure 5A. Peptides were synthesized to
represent phosphorylation sites withinMps1 that conform to the Plk1/Mps1 consensus or were previously annotated asMps1 autophosphorylation sites (marked
by asterisks). T/S, Thr/Ser phosphoacceptor; A, Ala in position of the phosphoacceptor.
(D) Mixtures of recombinant Plk1 and kinase-dead Mps1 were subjected to in vitro kinase assays before phosphorylations on Mps1 (pS/pT) were mapped by
mass spectrometry. Phosphopeptides were identified either with Mascot/Scaffold (M/S) or MaxQuant/Andromeda (MQ/A) with a decoy FDR of 0.01 on peptide
spectrum matches as significance cutoff (Table S1). Asterisks indicate Mps1 autophosphorylation sites.
(E) Schematic summarizes Plk1-dependent phosphorylations onMps1, as detected in the assays shown in (C) and (D), as well as Table S1. AnnotatedMps1 auto-
phosphorylation sites are highlighted in blue.
See also Table S1.Plk1 Targets Mps1 Autophosphorylation Sites
Our identification of KNL-1 as a common substrate for Plk1 and
Mps1 readily explains the observed effects of kinase inhibition
on Bub3:Bub1/BubR1 localization. This left open the question of
how Plk1 and Mps1 cooperate in the KT recruitment of the
Mad1:C-Mad2 complex. A priori, Plk1 could either phosphorylate
Mad1or its interaction partners, or, alternatively, enhance the abil-
ity of Mps1 to recruit Mad1. To explore this latter possibility, we
asked whether Plk1 is capable of phosphorylating Mps1. When
assayed in vitro, Plk1 readily phosphorylated kinase-dead Mps1(Figure S6A), confirming earlier data (Dou et al., 2011). Moreover,
Plk1 was able to rapidly stimulate wild-type Mps1 autophosphor-
ylation (Figures 6A and 6B). To identify the sites targeted by
Plk1, we carried out two types of experiments. First, peptides
representing all annotated Mps1 phosphorylation sites, as well
as putative Plk1 sites, were spotted onto membranes and tested
as substrates in kinase assays (Figure 6C). We found that 12
sites within Mps1 were efficiently phosphorylated by Plk1 and,
notably, 7 of these had previously been annotated as Mps1 auto-
phosphorylation sites (Dou et al., 2011; Jelluma et al., 2008; TylerCell Reports 12, 66–78, July 7, 2015 ª2015 The Authors 73
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et al., 2009;Xuet al., 2009). Second,mass spectrometrywasused
to map phosphorylation sites in kinase-dead Mps1 that had been
phosphorylated in vitro by Plk1; this resulted in the detection of 11
sites,ofwhich7hadpreviouslybeenattributed toMps1autophos-
phorylation (Figure 6D; Table S1). In total, we identified 17 distinct
sites targetedbyPlk1, including9 purportedMps1autophosphor-
ylation sites (Figures 6E and S6B). Most of these 17 sites were
highly conserved in vertebrates, and 12 could also be detected
in immunoprecipitated Mps1, arguing that these sites are also
phosphorylated in vivo (Figure S6B; Table S1). Taken together,
these results demonstrate that Plk1 is capable of phosphorylating
Mps1 on residues previously characterized as autophosphoryla-
tion sites. This conclusion is further supported by data identifying
three of the aforementioned sites (Thr33, Ser37 and Ser363) as
being both responsive to Plk1 inhibition in vivo (Dou et al., 2011;
Oppermann et al., 2012) and capable of serving as Mps1 sub-
strates in vitro (Jelluma et al., 2008; Xu et al., 2009).
Plk1 Enhances Mps1 Kinase Activity and KT
Dissociation
Most of the residues identified as common targets for Plk1 and
Mps1 are located within or near the N-terminal KT-binding
domain of Mps1 (Figure 6E), and several of these, including
Thr33, Ser37, Ser321, Thr363, and Thr371, are implicated in
Mps1 turnover at KTs (Wang et al., 2014). Moreover, previous
studies have shown that Mps1 promotes its own dissociation
from KTs (Hewitt et al., 2010; Jelluma et al., 2010; Santaguida
et al., 2010). To explore the possibility that Plk1 might contribute
to modulate Mps1 turnover at KTs, we monitored the KT dy-
namics of GFP-tagged wild-type Mps1 expressed in RPE-1
Mps1 null cells (Maciejowski et al., 2010). As predicted, KT levels
of Mps1 increased significantly in the presence of a Plk1 inhibi-
tor, and this increase was additive to the effect of Mps1 inhibition
(Figure 7A). In contrast, no marked changes in the KT levels of
Hec1, a putative binding partner of Mps1, were detected (Fig-
ure S7A). To corroborate and extend these results, we also car-
ried out FRAP experiments (Figure 7B;Movie S5). In control cells,
Mps1 showed a short recovery half-time of 1 s after photo-
bleaching and a small immobile fraction (4%), in excellent agree-
ment with previous data (Jelluma et al., 2010). Inhibition of Plk1Figure 7. Plk1 Enhances Mps1 Kinase Activity and KT Dissociation
(A) Mps1 null cells ectopically expressing GFP-tagged Mps1 were treated with n
[Rev], 5 mM ZM-447439) before GFP-Mps1 KT levels were recorded by live-cell m
from 45–50 cells per condition). Bottom: representative GFP KT signals.
(B) Cells described in (A) were incubated with nocodazole, MG132, and kinase in
croscopy (Movie S5). After 2 s, a single KT pair was bleached (top left), and fluoresc
recovery (n = 17–20 KT pairs per condition); shaded areas represent SEM. t1/2, h
(C) Asynchronously growing cells, as used in (A and B), were incubated with nocod
lapse microscopy (Movie S6). Left: stills show data obtained from60min (G2 ph
indicate premature KT association of GFP-Mps1. Right: scatterplot shows GFP-
(D) RPE-1 cells were synchronized in metaphase using MG132 and subsequen
assessed by staining with an antibody directed at phospho-Thr676. Histogram sh
Figure S7B). Error bars indicate SEM. rel. signal int., relative signal intensity.
(E) Asynchronously growing RPE-1 cells were incubated for 2 hr with kinase inhib
phosphorylation (P-Thr676). IF staining (right) shows KT levels of P-Thr676; sca
indicated mitotic stages (n = 19–38 cells per condition). Mitotic phases were clas
(F) Schematic illustrating the proposed involvement of Plk1 in SAC signaling at K
Scale bars, 5 mm. *p = 0.0115; **p = 0.0013; ***p < 0.001 (from Student’s t tests)caused a nearly 2-fold increase in the half-time and a 3-fold in-
crease in the immobile fraction (to 13%). In comparison, Mps1
inhibition increased the half-time to 2 s and the immobile fraction
to 17%. Most important, the combined inhibition of both Plk1
and Mps1 produced additive effects, resulting in a half-time of
4 s and an immobile fraction of 25%. Furthermore, we noticed
that combined inhibition of the two kinases led to premature
KT recruitment of GFP-Mps1 during the G2 phase (Figure 7C;
Movie S6). Since Plk1 localizes to KTs already during the S
and G2 phases (McKinley and Cheeseman, 2014) and is at least
partially active several hours beforemitotic onset (Macurek et al.,
2008), it is attractive to speculate that this kinase helps to in-
crease Mps1 turnover at KTs during the G2/M transition.
The aforementioned data concur to suggest that phosphoryla-
tion of Mps1 by Plk1 contributes to stimulate Mps1 activity and
strengthen SAC signaling. To further support this conclusion,
we used phospho-specific antibodies against Thr676, an auto-
phosphorylation site within the activation loop of Mps1 (Jelluma
et al., 2008), to monitor Mps1 activity in response to Plk1 phos-
phorylation. While inhibition of either Plk1 or Mps1 during SAC
establishment partially suppressed Thr676 phosphorylation at
KTs, simultaneous inactivation of both kinases reduced staining
below the detection limit (Figures 7D and S7B). Identical results
were also observed in the absence of nocodazole (Figure 7E),
and similar results were obtained with an antibody that detects
phosphorylated Thr686 (Tyler et al., 2009) (Figure S7C), an auto-
phosphorylation site essential for activity located within the P + 1
loop (Jelluma et al., 2008;Mattison et al., 2007; Tyler et al., 2009).
Thus, use of phospho-specific antibodies strongly supports
the conclusion that Plk1 potentiates Mps1 functionality in the
SAC through direct phosphorylation of Mps1, which, in turn, in-
creases Mps1 activity and turnover at KTs.
DISCUSSION
The specificity of kinases and phosphatases for their physiolog-
ical substrates stays at the heart of all signaling pathways. This
specificity is largely determined by two key parameters that
have been referred to as motif space and localization space
(Alexander et al., 2011). According to this model, the target rangeocodazole, MG132, and kinase inhibitors (100 nM BI-2536, 500 nM Reversine
icroscopy. Top: scatterplot shows intensity of GFP signals (n = 157–241 KTs
hibitors, and GFP-Mps1 KT levels were monitored by 500-ms time-lapse mi-
ence recoverywasmeasured (bottom). Top right: traces illustrate fluorescence
alf-time; plat., plateau.
azole and kinase inhibitors before fluorescence at KTs wasmonitored by time-
ase) to +10 min (M phase) relative to the time of mitotic entry (t = 0). Arrowheads
Mps1 intensity at KTs (50 KTs from ten cells per condition).
tly treated with nocodazole and kinase inhibitors. Mps1 activation state was
ows staining intensity (n = 75–79 cells per condition; micrographs are shown in
itors in the absence of nocodazole and then stained for Mps1 activation loop
tterplot (left) indicates P-Thr676 staining intensities at KTs, determined at the
sified as described in the legend for Figure 2. fluor. int., fluorescence intensity.
Ts. P, phosphorylation.
. See also Figure S7B and Movies S5 and S6.
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of kinases depends on, first, consensus motifs within substrate
proteins and, second, subcellular localization. Recently, two
key mitotic kinases, Plk1 and Mps1, were found to display an
intriguing overlap in both localization and motif space (Dou
et al., 2011; Hennrich et al., 2013). In this study, we have ad-
dressed the question of how to reconcile this discovery with
the apparently different physiological functions of these kinases.
We show that Plk1 cooperates with Mps1 in SAC signaling,
although this role is generally obscured by other functions of
Plk1—notably, its role in bipolar spindle formation. We further
demonstrate that Plk1makes positive contributions to twomajor
KT-associated branches of the SAC signaling pathway. In partic-
ular, we have identified two key SAC components that are phos-
phorylated on identical sites by Plk1 and Mps1—notably, KNL-1
andMps1 itself. While phosphorylation of KNL-1 onMELTmotifs
triggers the recruitment of the Bub3:BubR1 complex, phosphor-
ylation of Mps1 contributes to enhance Mps1 activity and turn-
over at KTs. This Mps1 activation, in turn, is essential for the
recruitment of the Mad1:C-Mad1 complex to KTs. While addi-
tional substrates shared between Plk1 and Mps1 are likely to
await discovery, our present data suggest cooperation between
the two kinases in both KT pathways that are central to the pro-
duction of the APC/C-inhibitory MCC (Figure 7F).
It has been argued that the SAC operates as a bi-stable switch
(Rieder and Maiato, 2004), but recent studies demonstrate that
the strength of SAC signaling is proportional to the number of un-
attached KTs (Collin et al., 2013; Dick andGerlich, 2013; Heinrich
et al., 2013). As shown here, Plk1 contributes to the augmenta-
tion of the strength of SAC signaling, which is expected to sensi-
tize cellular responses to unattached KTs. This may be of partic-
ular importance at very early stages of mitosis, when MCC
production needs to ramp up, or shortly before anaphase onset,
when only a few unattached KTs remain available for MCC pro-
duction. A similar function has been proposed for Aurora B,
which potentiates SAC signaling at the onset of mitosis by re-
cruiting Mps1 to KTs (Saurin et al., 2011).
It is interesting to consider the cooperation between Plk1 and
Mps1 from an evolutionary perspective. One plausible scenario
is that the relative contributions ofMps1andPlk1 toSACsignaling
differ between organisms. An extreme example for this can
be seen in Caenorhabditis elegans, whose genome lacks a re-
cognizable gene for Mps1, although both Mad1:C-Mad2 and
Bub3:Bub1/BubR1, aswell asKNL-1 andMELTmotifs, are clearly
present (Vleugel et al., 2012). An independent study demonstrates
that Plk1 phosphorylates the KNL-1 MELT repeats in C. elegans,
suggesting that functions commonly attributed to Mps1 in verte-
brates are performed by Plk1 in this nematode (Espeut et al.,
2015), fully in linewith thedata reportedhere.Still another situation
holds in Drosophila melanogaster, where KNL-1 MELT motifs are
mostly degenerate, unphosphorylatable, and largely dispensable
for SAC function (Schittenhelm et al., 2009). However, in
Drosophila, Mad1 localization also depends on Mps1, and Polo
contributes to the recruitment of Mps1 to KTs (Althoff et al.,
2012; Conde et al., 2013). Collectively, these data suggest that
the contribution of Plk1 to SAC signaling is likely to be auxiliary
toMps1 inmanyorganismsor cell typesbut apparently indispens-
able in others. This consideration may also be relevant to tumori-
genesis. Althoughmany human tumors showchromosomal insta-76 Cell Reports 12, 66–78, July 7, 2015 ª2015 The Authorsbility, aneuploid tumor cells still depend on SAC functionality to
prevent lethality (Holland and Cleveland, 2009). It is remarkable,
therefore, that high levels of Mps1 were shown to protect aneu-
ploid cells (Daniel et al., 2011) and that elevated expression of
Plk1 is often observed in human cancers (Strebhardt, 2010).
Therefore, it is tempting tospeculate that thecooperationbetween
Mps1andPlk1maybe important to strengthen theSAC in tumors,
whichmayproveparticularly critical in cells that undergomitosis in
the presence of hyperdiploid numbers of chromosomes. If this
were the case, the simultaneous inhibition ofMps1 andPlk1might
constitute an attractive strategy for anti-cancer therapy.
EXPERIMENTAL PROCEDURES
rAAV-Mediated Gene Targeting
Homology arms to human Mad2 (MAD2L1), Aurora B (AURKB), and Bub3
(BUB3L) genes were amplified from RPE-1 cell genomic DNA. Targeting con-
structs were assembled by four-piece ligation in a NotI-digested pAAV vector.
Recombinant adenovirus-associated virus (rAAV) particles were generated as
previously described (Berdougo et al., 2009). RPE-1 cells were infected with
3 ml of viral supernatant for 48 hr and then expanded into fresh medium for
an additional 48 hr. They were synchronized with RO-3306 (10 mM) for 18 hr,
released into nocodazole (50 nM) for 2 hr, and then subjected to fluores-
cence-activated cell sorting (FACS). Cells were trypsinized and kept in PBS
supplemented with nocodazole (10 nM) during sorting. Infected cells were
filtered (30 mm, Partec), and EGFP-positive cells (488 excitation, 514/30 emis-
sion filter) were isolated on an Aria III (BD Biosciences) cell sorter, as previously
described (Collin et al., 2013). In brief, cells were selected using the 514/30
channel against a 585/42 filter detecting auto-fluorescence of uninfected cells.
Single cells were sorted into 96-well plates filled with conditionedmedium, and
positive clones were identified by fluorescence microscopy.
FRET Reporter Cloning
FRET reporters used in this study are based on a sensor design in which phos-
phorylation of a target sequence triggers the binding of a phosphate-binding
(FHA2) domain and concomitant changes in intra-molecular FRET between
CFP and yellow fluorescent protein (YFP). Sensors harboring the KNL-1
MELT motif around Thr875 (or Ala for control) were constructed by Quick-
Change mutagenesis (Agilent Technologies) of a plasmid encoding Aurora B
H2B-fused biosensors (Fuller et al., 2008). The Aurora B sequence in the re-
porter was replaced with the sequence SEDDKNDMDI(T/A)KSI; the Ile in posi-
tion +3 relative to the phospho-acceptor was included to promote FHA2
domain binding.
Standard Procedures
Cell culture, transfections, western blotting, immunoprecipitation, fluores-
cence microscopy, in vitro kinase assays, and mass spectrometry were car-
ried out as described in detail in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, one table, and six movies and can be found with this article on-
line at http://dx.doi.org/10.1016/j.celrep.2015.06.007.
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